Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1669) clinical trials

People with well-differentiated metatatic and/or unresectable typical or atypical lung neuroendocrine tumors are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

To characterize the safety, tolerability, pharmacokinetics and immunogenicity of anetumab ravtansine in subjects with advanced solid cancers and with different degrees of hepatic or renal impairment

Phase

People with lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

Determine the safety, tolerability and maximum tolerated dose of anetumab ravtansine (BAY 94-9343) in combination with pemetrexed 500 mg/m2 and cisplatin 75 mg/m2 in subjects with mesothelin-expressing predominantly epithelial mesothelioma or nonsquamous non-small-cell lung cancer.

Phase

The purpose of this study is to determine whether AZD9291 may be more effective than standard therapy in extending the time before your lung cancer gets worse.

Phase

People with advanced or metastatic non-small cell lung cancer are asked to prescreen for a research study being conducted by Montefiore Medical Center.

Phase N/A

Researchers at the University of Kentucky are seeking candidates to participate in a study for possibvle new cancer treatment. Exatherm Total Body Hyperthermia System (Exatherm-TBH) is an investigational medical device treatment that will be performed in an inpatient setting and lasts approximately four hours.

Phase N/A

The primary efficacy objective of the study is to evaluate the efficacy of 16 cycles of Atezolizumab (MPDL3280A) treatment compared with best supportive care as measured by disease-free survival (DFS) as assessed by the investigator.

Phase

This randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin and paclitaxel with or without bevacizumab compared with treatment with carboplatin plus (+) paclitaxel and bevacizumab in chemotherapy-naïve patients with Stage IV non-squamous non-small cell lung cancer (NSCLC).

Phase

The purpose of this study is to compare any good and bad effects of using the anti-diabetic drug, metformin along with the standard of care radiation therapy and chemotherapy to using the standard of care radiation therapy and chemotherapy alone. The addition of metformin to the usual radiation and chemotherapy ...

Phase